INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 7 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,405,000 | -30.4% | 773,816 | 0.0% | 0.25% | -31.0% |
| Q1 2018 | $4,894,000 | +17.4% | 773,816 | -4.4% | 0.36% | -16.5% |
| Q4 2017 | $4,170,000 | -42.5% | 809,804 | 0.0% | 0.44% | -65.9% |
| Q3 2017 | $7,248,000 | +57.0% | 809,804 | 0.0% | 1.28% | +67.3% |
| Q2 2017 | $4,616,000 | +11.5% | 809,804 | 0.0% | 0.76% | +27.3% |
| Q1 2017 | $4,140,000 | -10.3% | 809,804 | 0.0% | 0.60% | -3.4% |
| Q4 2016 | $4,616,000 | -3.1% | 809,804 | 0.0% | 0.62% | +18.5% |
| Q3 2016 | $4,762,000 | +27.9% | 809,804 | 0.0% | 0.52% | -0.6% |
| Q2 2016 | $3,724,000 | +13.0% | 809,804 | +1.2% | 0.53% | +6.2% |
| Q1 2016 | $3,296,000 | -23.1% | 800,000 | 0.0% | 0.50% | -3.1% |
| Q4 2015 | $4,288,000 | -4.3% | 800,000 | 0.0% | 0.51% | -28.4% |
| Q3 2015 | $4,480,000 | – | 800,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |